FDA Approves Pembrolizumab With Enfortumab Vedotin-ejfv for Muscle-Invasive Bladder Cancer

The FDA approved this application 5 months ahead of the FDA goal date. … © 2025 HSP News Service, L.L.C.. Conexiant Oncology Logo · Editorial Board …